Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PFKFB3 | Q16875 | 7/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | CD38 | P28907 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5434980 | 1.00 | PFKFB3 (0.39) | PFKFB3HDAC6CD38LMNAUSP2 | |
| SCHEMBL1551293 | 1.00 | PFKFB3 (0.39) | PFKFB3HDAC6CD38LMNAUSP2 | |
| SCHEMBL1551824 | 0.86 | LMNA (0.45) | PFKFB3HDAC6CD38LMNADHFR | |
| SCHEMBL3212547 | 0.86 | LMNA (0.45) | PFKFB3HDAC6CD38LMNADHFR | |
| SCHEMBL1551901 | 0.86 | LMNA (0.45) | PFKFB3HDAC6CD38LMNADHFR | |
| SCHEMBL11960084 | 0.85 | IDO1 (0.34) | PFKFB3LMNAMAPT | |
| SCHEMBL11960138 | 0.85 | IDO1 (0.34) | PFKFB3LMNAMAPT | |
| SCHEMBL1551887 | 0.83 | LMNA (0.32) | LMNAMAPT | |
| SCHEMBL1551748 | 0.83 | LMNA (0.32) | LMNAMAPT | |
| SCHEMBL3205862 | 0.83 | LMNA (0.32) | LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | SLC43A1, AS3MT, SLC7A5 | PFKFB3 872/4885HDAC6 3446/4885CD38 3534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.